The role of exogenous peptides in restoration
of full immune response under secondary
immunodeficiency
A.I. Kurchenko, V.A. Benyuk, H.P. Potebnya,
V.L. Kobys, O.F.Tatskyy, O.S. Neymark
The aim of the research: defining the role of immunomodulation with the use of exogenous peptides MHP (CamelynBio)
on the effectiveness of treatment of cervical dysplasia III that
was caused by mixed chlamydia and human papillomavirus
infection.
Materials and methods. In accordance with the objectives of
the study we selected and randomized 72 patients with dysplasia (paplomaviruschlamydial etiology). Women were
divided into two groups: basic (n=36) and control (n=36)
matched by age, symptoms and duration of the process. The
main conventional treatment group received CamelynBio
capsules at a dose of 1 capsule (0.19 g) 3 times a day 30 days
from starting treatment.
Results. The result of the reduction in viral load lower than a
clinically significant threshold (3 lg) was achieved in 70% of
patients in control group and 77,8% in the main group.
Therefore, adequate complex therapy taking into account the
role of exogenous peptides reduces the activity of HPV, promotes its elimination, reduces the frequency of relapses. The
effectiveness of combined therapy of mild cervical dysplasia
with the use of CamelynBio was 88.9%. In the group of
patients receiving standard therapy, the efficacy was 83.4%.
Conclusion. Now to resolve vital clinical tasks a practitioner
has an innovative agent CamelynBio, which, in particular,
speeds up the elimination of HPV in women of childbearing age.
The inclusion of CamelynBio in the traditional scheme of treatment of cervical dysplasia is justified etiopatogeneticaly and
allows to harmonize the immune homeostasis of patients and
allows to increase the effectiveness of treatment